Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?
- PMID: 16678260
- DOI: 10.1016/j.leukres.2006.03.014
Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?
Comment on
-
In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies.Leuk Res. 2006 Sep;30(9):1151-8. doi: 10.1016/j.leukres.2006.02.016. Epub 2006 Mar 20. Leuk Res. 2006. PMID: 16542724
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
